AFCR News

Sarcoma Origin Identified

Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in the skeleton…...

Read more

Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer

The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is the world’s first global adaptive clinical trial platform…...

Read more

AFCR Scientific Advisory Board Chairman’s Brain Cancer Efforts Recognized

W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was…...

Read more

Yoga for Insomnia, Anxiety and Socializing in Cancer Patients

A discipline consisting of movements through a sequence of postures in coordination with focused breathing, yoga’s documented benefits include increased flexibility, better strength, lowered blood pressure and the reduced severity of insomnia. Many people attribute recovery from depression and anxiety to the regular practice of yoga. Could its practice be…...

Read more

Spurring on the Next Generation

The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association jointly awarded six outstanding Chinese cancer researchers in the early stages of their careers with the 2018 USCACA-AFCR Young Investigator Award. Scholars received a certificate for the Award and a cheque in the amount of U.S. $1,000 in…...

Read more

New Faces

The Asian Fund for Cancer Research is pleased and honored to have recently both expanded its board of directors and established a council of advisors. Franck Le Deu, a senior partner in the Hong Kong office of McKinsey & Company, where he leads the consultancy’s pharmaceuticals and medical products practice…...

Read more

The Pathfinder

The “Ras/Raf/MEK/ERK pathway” is a mouthful. Oncologists will tell you the same thing. But behind the long phrase is an important field of cancer research—one in which Jiancheng Hu, Ph.D., a scientist supported by the Asian Fund for Cancer Research since 2017, is a renowned expert. Ras is a family…...

Read more

Confronting Cancer Together—as One City

The Asian Fund for Cancer Research was proud to have been among the 50-plus organizations and companies to have participated in the Hong Kong Anti-Cancer Society’s Hong Kong Cancer Day activities, held Sunday, 9 December 2018. A full slate of family-friendly programming was presented to nearly 3,000 participants, including food,…...

Read more

World Cancer Day: How Far We’ve Come

World Cancer Day: How Far We’ve Come For the past two decades, people around the globe have bound together to promote cancer awareness every February 4th, World Cancer Day. The Asian Fund for Cancer Research is honored to be one of over a thousand members of the Day’s coordinator, the…...

Read more

Making Progress

This past fall saw considerable progress in the development of GBM AGILE, the brain cancer clinical trial initiative whose early-stage planning has long been supported by the Asian Fund for Cancer Research. Not only was an acting head hired to run the Global Coalition for Adaptive Research (GCAR), the non-profit…...

Read more